| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/28/2005 | CN1674936A Treatment of MS with goat serum |
| 09/28/2005 | CN1674779A Method of expressing gene in transgenic birds using retrovirus vector and transgenic birds thus obtained |
| 09/28/2005 | CN1673744A Treatment and diagnosis of cancer |
| 09/28/2005 | CN1673372A A novel marnifi blue mold cell wall surface antigen II its coding sequence and application thereof |
| 09/28/2005 | CN1673371A A new marnifi blue mold cell wall surface antigen I, its coding sequence and application thereof |
| 09/28/2005 | CN1673368A HCV regulated proteins |
| 09/28/2005 | CN1673232A Receptor DR5 monoclonal antibody (AD5-10) resisting human tumor necrosin related apoptosis inducing ligand and its prepn and use |
| 09/28/2005 | CN1673231A Monoclonal antibody of SARS coronavirus N protein and its application |
| 09/28/2005 | CN1220776C Efficient expression system of genetically engineered antibody eukaryon and its preparing process and application |
| 09/28/2005 | CN1220521C Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 09/27/2005 | US6949636 Intron/exon structure of the human and mouse β3-adrenergic receptor genes |
| 09/27/2005 | US6949628 Detection of infections in humans; obtain sample, incubate with antibody, detect signal, presence of signal indicates infection |
| 09/27/2005 | US6949626 Bacillus thuringiensis cryET33 and cryET34 compositions and uses therefor |
| 09/27/2005 | US6949366 Complexing; purified polypeptide |
| 09/27/2005 | US6949363 An antisense compound 8 to 30 nucleotides in length that specifically hybridizes to a nucleic acid molecule(cDNA) encoding the human leucin-rich repeat bone marrow protein or polypeptide to prevent the expression of such protein |
| 09/27/2005 | US6949360 DNA coding for human cell surface antigen |
| 09/27/2005 | US6949357 Reagents and methods useful for detecting diseases of the urinary tract |
| 09/27/2005 | US6949353 capable of acting as an guanylyltransferase and methyltransferase consisting of a polypeptide from the N-terminus of flavivirus genus RNA-dependent RNA polymerase |
| 09/27/2005 | US6949349 incubating a phagemid clone displaying the peptide, with the IGF in the presence of the IGFBP at high and low concentrations of the phagemid clone, measuring the degree to which binding of the phagemid clone to the IGFBP is inhibited by IGF |
| 09/27/2005 | US6949346 Using antibody released by hybridomas cells |
| 09/27/2005 | US6949345 Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin |
| 09/27/2005 | US6949337 Contacting human vpr interacting protein with a test compound and comparing the affinity of the vpr in the presence and absence of it |
| 09/27/2005 | US6949246 Monoclonal/polyclonal antibodies for serodetection and treatment of mycobacterium infections |
| 09/27/2005 | US6949245 Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies |
| 09/27/2005 | US6949244 produced by hybridoma cell line ATCC No. HB 12020; elicits an immune response against (human milk fat globule) HMFG in non-human primates |
| 09/27/2005 | US6949243 administering an anti-SDF-1 or anti-CXCR4 antibody or binding fragment |
| 09/27/2005 | CA2149120C Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 09/27/2005 | CA2108104C Fibrin sealant compositions and methods for utilizing same |
| 09/27/2005 | CA2099612C Monokine mig induced by ifn-gamma |
| 09/26/2005 | WO2005110452A2 MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFα-RELATED DISORDERS |
| 09/26/2005 | CA2847331A1 Multiple-variable dose regimen for treating tnf.alpha.-related disorders |
| 09/26/2005 | CA2847142A1 Multiple-variable dose regimen for treating tnf.alpha.-related disorders |
| 09/26/2005 | CA2504868A1 Multiple-variable dose regimen for treating tnf.alpha. related disorders |
| 09/22/2005 | WO2005088307A1 Immunoassays for everolimus |
| 09/22/2005 | WO2005087954A2 Roles of foxc2, pdgfr, vegfr3 in lymphatic vessel development |
| 09/22/2005 | WO2005087915A2 Use of ethanolamine for enhancing cell growth in membrane systems |
| 09/22/2005 | WO2005087812A1 Multivalent antibody materials and methods for vegf/pdgf family of growth factors |
| 09/22/2005 | WO2005087811A2 Estrogen receptors and methods of use |
| 09/22/2005 | WO2005087808A2 Growth factor binding constructs materials and methods |
| 09/22/2005 | WO2005087807A1 Vr1 receptors and uses thereof |
| 09/22/2005 | WO2005087806A2 Cd38 splice variant and uses thereof |
| 09/22/2005 | WO2005087802A2 Process for producing polypeptides |
| 09/22/2005 | WO2005087796A1 Novel phosphorylated sequences of phosphatase cdc25b, antibodies directed against said sequences and use thereof |
| 09/22/2005 | WO2005087268A1 Axon regeneration promoter |
| 09/22/2005 | WO2005087264A1 Cd44-targeting for reducing/preventing ischemia-reperfusion-injury |
| 09/22/2005 | WO2005087177A2 Chimeric anti-vegf-d antibodies and humanized anti-vegf-d antibodies and methods of using same |
| 09/22/2005 | WO2005086875A2 A humanized anti-cea t84.66 antibody and uses thereof |
| 09/22/2005 | WO2005086698A2 Methods for altering t cell diversity |
| 09/22/2005 | WO2005086612A2 Fluorinated carbohydrate conjugates |
| 09/22/2005 | WO2005086595A2 Telomere protein trf2 dna-binding domain mutant protein, telomere dna mutant and utilization of complex structure of trf2 dna-binding domain with double-stranded dna |
| 09/22/2005 | WO2005086568A2 Anti-icam-1 human antibodies and uses thereof |
| 09/22/2005 | WO2005066210A3 Compositions and methods for treating t-cell mediated autoimmune diseases |
| 09/22/2005 | WO2005061540A3 Method for the humanization of antibodies and humanized antibodies thereby obtained |
| 09/22/2005 | WO2005038006A8 Chimeric metabotropic glutamate receptors and uses thereof |
| 09/22/2005 | WO2005029082A3 Methods for the in vitro diagnosis and in vitro prognosis of cancer of the pancreas and for the development of drugs against cancer of the pancreas and/or pancreatitis |
| 09/22/2005 | WO2005021734A3 Generation of hematopoietic chimerism and induction of central tolerance |
| 09/22/2005 | WO2005020799A3 METHOD FOR MEASURING FCϵRII/CD23 IGE RECEPTOR IN HUMAN FECES AS AN INDICATOR OF A TH2 PREDOMINANT IMMUNE RESPONSE INVOLVED IN GASTROINTESTINAL ILLNESSES |
| 09/22/2005 | WO2004056316A8 Vaccines against hiv-1 tat protein to generate neutralizing antibodies |
| 09/22/2005 | US20050210535 Parasite integral membrane protein for use as tool in identifying modulators and devlopment of vaccines for prevention and treatment of toxoplasmosis |
| 09/22/2005 | US20050209443 Flavor active modified thaumatin and monellin and methods for their production and use |
| 09/22/2005 | US20050209442 Glycine extraction of a water and ethanol suspension of the immunoglobulins, followed by anion exchange chromatography to achieve a significantly high yield and high purity |
| 09/22/2005 | US20050209153 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
| 09/22/2005 | US20050208631 Polypeptide of N-acetylglucosamine-6-O-sulfotransferase and DNA encoding the same |
| 09/22/2005 | US20050208628 Methods and vectors for generating antibodies in avian species and uses therefor |
| 09/22/2005 | US20050208627 Elicitation of antibodies to self peptides in mice by immunization with dendritic cells |
| 09/22/2005 | US20050208625 Monoclonal antibodies with reduced immunogenicity |
| 09/22/2005 | US20050208619 29 human secreted proteins |
| 09/22/2005 | US20050208607 Immunoassays for everolimus |
| 09/22/2005 | US20050208604 An amphetamine and a methamphetamine group linked by a linking group, a polyamino acid or a nonpolyamino acid label linked to a second linking group which is attached to first linking group at a equidistance from both drugs, and second linking group terminates in a functional group; antiboides; sample |
| 09/22/2005 | US20050208603 Using enzyme complexes; forming antibodies; measuring signals; calibration |
| 09/22/2005 | US20050208599 Using immunoglobulins specific to dendritic cell-specific adhesion receptors (DC-SIGN) as tool in isolation of preferential nervous system tissues |
| 09/22/2005 | US20050208596 Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof |
| 09/22/2005 | US20050208591 Antibodies to chemokine alpha-6 |
| 09/22/2005 | US20050208587 Fab 4E10/KGND crystal complex for use in preparing viricidal agents; rational drug design |
| 09/22/2005 | US20050208586 Using modified serum proteins as biosensor tools in proteomics, protein expression profiling, drug discovery and efficacy, environmental screening and bio-defense |
| 09/22/2005 | US20050208585 Immunoglobulin soecific to thrombopoietin (TPO) receptor for use in treatment of thrombocytopenia |
| 09/22/2005 | US20050208580 Novel protein and method for producing the protein |
| 09/22/2005 | US20050208566 Using enzymatic membrane protein as tool in identifying modulators for prevention and treatment of atherosclerotic, inflammatory and cell proliferative disorders |
| 09/22/2005 | US20050208565 29 human cancer associated proteins |
| 09/22/2005 | US20050208560 Using immunoglobulins to identify staphylococcal peptides associated with viriginiamycin resistant |
| 09/22/2005 | US20050208559 directed toward modulating oxidative damage to intracellular components such as mitochondrial DNA (mtDNA) and mitochondrial protein; antibody, or fragment thereof, that specifically binds to enzyme |
| 09/22/2005 | US20050208552 Corpuscles of Stannius protein, stanniocalcin |
| 09/22/2005 | US20050208546 Nucleotide sequences coding tumor associated antigens for use as tool in diagnosis, prevention and treatment of cell proliferative disorders |
| 09/22/2005 | US20050208540 Novel fibroblast growth factor and nucleic acids encoding same |
| 09/22/2005 | US20050208525 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response |
| 09/22/2005 | US20050208508 Gene encoding labyrinthin, a marker for cancer |
| 09/22/2005 | US20050208507 Human RPS6KA6-related gene variant associated with lung cancers |
| 09/22/2005 | US20050208498 Killer cell immunoglobulin-like receptor (KIR)-like protein receptor for use in diagnosis, prevention and treatment of cancer, autoimmune disease, organ transplant rejection, allergic reaction, and inflammatory disorders |
| 09/22/2005 | US20050208492 Regulation of human serine/threonine kinase |
| 09/22/2005 | US20050208484 Isolated nucleic acid molecules encoding human drugmetobolizing proteins |
| 09/22/2005 | US20050208483 Kits for detecting anti-sirs antibodies |
| 09/22/2005 | US20050208481 Using feline immunedeficiency viral (FIV) envelope protein as screening tool in monoclonal antibody detection |
| 09/22/2005 | US20050208480 aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies |
| 09/22/2005 | US20050208479 Immunoglobulin for prevention of variola infection; immunotherapeutics |
| 09/22/2005 | US20050208103 Contacting sclera with a therapeutic or diagnostic agent so as to permit its passage into the choroidal and retinal tissues; no significant systemic absorption or tissue damage; eye disorders |
| 09/22/2005 | US20050208079 Glucan-based vaccines |
| 09/22/2005 | US20050208065 Immunogenic compositions for induction of anti-tumor immunity |
| 09/22/2005 | US20050208063 Vaccine containing a thiol protease |
| 09/22/2005 | US20050208058 For treatment of cell proliferative by modulating/inhibiting centrosomal genes or polypeptides via gene silencing, antibodies, aptamers, ribozymes, and antisense nucleic acids; gene expression inhibition; tubulins |
| 09/22/2005 | US20050208057 Metadherin polypeptides, encoding nucleic acids and methods of use |